Related Experiment Videos
[Polymyositis and essential thrombocytopenia. A case report]
C Auzary1, F Lhote, A Buoncuore
1Service de Médecine Interne, Hôpital Delafontaine, 2, rue Pierre-Delafontaine, 93200 Saint-Denis.
Annales De Medecine Interne
|January 5, 2001
Summary
This case report details a rare simultaneous diagnosis of polymyositis (PM) and essential thrombocytemia (ET). While PM responded to treatment, ET led to fatal complications, highlighting the importance of investigating PM associations.
Area of Science:
- Neurology
- Hematology
- Oncology
Background:
- Polymyositis (PM) is linked to increased solid tumor risk.
- Lymphoma and chronic lymphoid leukemia are common hematologic malignancies associated with PM/dermatopolymyositis.
- Associations between PM and myeloproliferative disorders are exceptionally rare.
Observation:
- This report describes the first simultaneous presentation of polymyositis and essential thrombocytemia (ET).
- The patient's polymyositis showed a significant and rapid response to corticosteroid treatment.
- Essential thrombocytemia presented with severe thrombotic and hemorrhagic complications.
Findings:
- The polymyositis demonstrated notable sensitivity to corticosteroids, achieving swift clinical and biological control.
- Despite effective cytostatic treatment for essential thrombocytemia, the patient succumbed to its complications.
- This case represents the first documented instance of concurrent polymyositis and essential thrombocytemia.
Implications:
- This case underscores the rare paraneoplastic significance of polymyositis in relation to myeloproliferative disorders.
- It highlights the critical need for thorough investigation of potential underlying hematologic malignancies in polymyositis patients.
- Further research is warranted to understand the complex interplay between inflammatory myopathies and myeloproliferative neoplasms.